STOCK TITAN

BillionToOne CTO sells 20,000 shares

BillionToOne’s chief technology officer exercised options and sold 20,000 shares under a Rule 10b5-1 plan.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BillionToOne, Inc. (BLLN) reported that Chief Technology Officer David Tsao exercised options to acquire 20,000 shares of Class A Common Stock at an exercise price of $2.80 per share on September 9, 2026, and sold 20,000 shares the same day in two transactions at $97.54 and $100.00 per share. These transactions were carried out under a Rule 10b5-1 trading plan adopted on June 5, 2026, and the options exercised were fully vested and exercisable.

Positive

  • None.

Negative

  • None.
Insider Tsao David
Role Chief Technology Officer
Sold 20,000 shs ($1.98M)
Approx. gross sale proceeds $1.98M
Approx. exercise cost $56K
Approx. pre-tax spread $1.92M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F2 10,000 $2.80 $28K
Exercise Stock Option (right to buy) F2 10,000 $2.80 $28K
Exercise Class A Common Stock F1 10,000 $2.80 $28K
Exercise Class A Common Stock F1 10,000 $2.80 $28K
Sale Class A Common Stock F1 10,000 $97.54 $975K
Sale Class A Common Stock F1 10,000 $100.00 $1.00M
Holdings After Transaction: Stock Option (right to buy) — 560,000 contracts (Direct); Class A Common Stock — 1,000 shares (Direct)
Footnotes (2)
  1. F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
  2. F2. The options are fully vested and exercisable.
Shares acquired via option exercise 20,000 shares Class A Common Stock acquired by exercising stock options on September 9, 2026
Option exercise price $2.80 per share Exercise price for 20,000 options exercised on September 9, 2026
Shares sold 20,000 shares Class A Common Stock sold on September 9, 2026
Sale prices $97.54 and $100.00 per share Prices for two 10,000-share sales of Class A Common Stock
Rule 10b5-1 plan adoption date June 5, 2026 Date David Tsao adopted the trading plan governing these transactions
Option expiration date June 7, 2031 Expiration date of the options that were exercised
Rule 10b5-1 trading plan regulatory
"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
fully vested and exercisable financial
"The options are fully vested and exercisable."
Class A Common Stock financial
"underlying security title Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BLLN’s CTO report on September 9, 2026?

David Tsao exercised options for 20,000 shares of Class A Common Stock at $2.80 per share and sold 20,000 shares the same day in two trades at $97.54 and $100.00 per share.

Were the BLLN insider trades by the CTO made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by David Tsao on June 5, 2026.

What stock option terms applied to the BLLN options exercised by the CTO?

David Tsao exercised stock options covering 20,000 shares of Class A Common Stock at an exercise price of $2.80 per share, with the options described as fully vested and exercisable and expiring on June 7, 2031.

How many BLLN shares did the CTO sell and at what prices?

He sold a total of 20,000 shares of Class A Common Stock on September 9, 2026, in two transactions: 10,000 shares at $97.54 per share and 10,000 shares at $100.00 per share.

Does the Form 4 disclose remaining BLLN holdings for the CTO after these transactions?

No specific post-transaction share holdings are stated in the reported data; only the option exercises and the 20,000 shares sold on September 9, 2026 are described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tsao David

(Last)(First)(Middle)
C/O BILLIONTOONE, INC.
1035 O'BRIEN DRIVE

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BillionToOne, Inc. [ BLLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/09/2026M(1)10,000A$2.811,000D
Class A Common Stock09/09/2026M(1)10,000A$2.821,000D
Class A Common Stock09/09/2026S(1)10,000D$97.5411,000D
Class A Common Stock09/09/2026S(1)10,000D$1001,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$2.809/09/2026M10,000 (2)06/07/2031Class A Common Stock10,000$2.8570,000D
Stock Option (right to buy)$2.809/09/2026M10,000 (2)06/07/2031Class A Common Stock10,000$2.8560,000D
Explanation of Responses:
1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
2. The options are fully vested and exercisable.
Remarks:
/s/ Thomas P. Lynch, Attorney-in-Fact09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading